Status:
TERMINATED
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
Lead Sponsor:
Organon and Co
Conditions:
Systemic Lupus Erythematosus
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Women with Systemic Lupus Erythematosus (SLE) are prone to cardiovascular disease. Early detection of improvement of endothelial function with simvastatin could be a clue for future intervention trial...
Eligibility Criteria
Inclusion
- Female Patients Over 18 Years Old
- Confirmed Systemic Lupus Erythematosus (SLE) diagnosis according to American College of Rheumatology (ACR)
- Signed Informed Consent Form (ICF)
Exclusion
- Patients With LDL-C Below 90 mg/dL
- Pregnant Or Breast Feeding
- Diabetes Mellitus
- Or Any Clinically Relevant Organ Disfunction
Key Trial Info
Start Date :
September 19 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00739050
Start Date
September 19 2007
End Date
February 1 2008
Last Update
May 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.